… gradient of hepatocellular carcinoma risk by (1) serum HBV DNA levels at … serum ALT level,
and presence of liver cirrhosis at study entry; and (2) persistent elevation of serum HBV DNA …

… in serum DNA for early detection of HCC. Experimental Design: Aberrant promoter
hypermethylation was investigated in DNA isolated from the serum of … was found in serum DNA 1 …

… serum cell-free DNA (cfDNA) and DNA integrity index for detection of hepatitis B virus (HBV)-related
hepatocellular carcinoma … of beta-actin genomic DNA fragments using two sets of …

… change in serum levels of HBV DNA over time is a strong risk predictor of hepatocellular
carcinoma, … Spontaneous decrease of HBV DNA levels to <10 4 copies/mL is associated with a …

… serum because mtDNA has a higher copy number than nuclear DNA. Thus, we examined
genetic alterations in the D-loop region of mtDNA in hepatocellular carcinoma (HCC) patients. …

… We used 5 μL of DNA not treated with enzyme or 7.15 μL of an enzyme-digested serum
DNA mixture (equivalent to 5 μL of undigested serum DNA) as the template for each reaction. …

… diagnostic accuracy of circulating tumor DNA (ctDNA) in hepatocellular carcinoma (HCC). …
Circulating tumor DNA displays a promising diagnostic potential in HCC. However, it is not …

… biomarkers in hepatocellular carcinoma (HCC). Circulating cell free deoxyribonucleic acid
(cfDNA) is a fragmented DNA subtype, found in the blood circulation. Circulating tumor DNA (…

… Furthermore, while serum DNA is significantly associated … DNA is predictive of recurrence,
indicating that serum DNA … that plasma DNA better reflects the in vivo levels of circulating DNA[…

… The potential diagnostic, prognostic, and monitoring significance of plasma/serum DNA
has been clearly demonstrated in breast cancer [5, 6], colorectal cancer [3], lung cancer [7–9], …